Dose-escalation, Repeated and Single Oral Dosing Study
Clinical trial NCT02419820 · TERMINATED
Trial details
- NCT number
- NCT02419820
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-04-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.